Purpose/Desired Learning Outcome
After participating in this activity, the participants should be better able to incorporate the latest advances in pharmacologic and lifestyle interventions for lowering cardiovascular risk. Identify novel approaches for risk assessment in primary and secondary prevention. Recognize challenges and opportunities for enhancing cardiovascular disease prevention.
ACCME Accreditation Statement
The Society of Cardiovascular Computed Tomography (SCCT) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Society of Cardiovascular Computed Tomography (SCCT) designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Complete the sessions in full for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted in your professional development journal.
Disclosure of Commercial Support
Commercial support was received for the 2022 Cardiovascular Disease Prevention Symposium live activity. Unrestricted educational grants from Cleerly, Inc. and Regeneron Health Solutions.
Bibliography
If references were cited, they will appear on the individual presentation slides.
Disclosure of Financial Relationships
The planners and faculty for this activity did not have any relevant relationships with ACCME- defined ineligible companies to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to The Standards for Integrity and Independence in Accredited Continuing Education.
|
Ron Blankstein |
Planner/Speaker |
1) Caristo, Elucid, Roivant 2) Amgen, Novartis |
1) Consultant/Honoraria 2) Grants and research support |
|
Robert Kushner |
Speaker |
Novo Nordisk, Lilly, Pfizer |
Consultant/Honoraria |
|
Michael Blaha |
Speaker |
Aetna, Amgen, Novo Nordisk |
Grants and research support |
|
Raul Santos |
Speaker |
1) Amgen 2) Abbott, Astra Zeneca, Novo Nordisk |
1) Grants and research support 2) Consultant/Honoraria |
|
Fatima Rodriguez |
Speaker |
1) Novartis 2) Nova Nordisk |
1) Grants and research support 2) Consultant/Honoraria |
|
Michael Shapiro |
Speaker |
1) Novartis, Amgen, Novo Nordisk 2) Regeneron |
1) Grants and research support 2) Consultant/Honoraria |
|
Matthew Budoff |
Speaker |
1) Novartis, Boehringer Ingleheim, Amgen 2) Amarin |
1) Grants and research support 2) Speaker's Bureau |
|
Nehal Mehta |
Speaker |
Abbvie, Norvartis, Janssen, Astra Zeneca |
Grants and research support |